{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T02:26:58Z","timestamp":1784773618837,"version":"3.55.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T00:00:00Z","timestamp":1656720000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T00:00:00Z","timestamp":1656720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"DST-SERB","award":["EMR\/2016\/005914"],"award-info":[{"award-number":["EMR\/2016\/005914"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s11010-022-04473-6","type":"journal-article","created":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T05:02:31Z","timestamp":1656738151000},"page":"229-240","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Investigating microRNAs in diabetic cardiomyopathy as tools for early detection and therapeutics"],"prefix":"10.1007","volume":"478","author":[{"given":"Priyanka","family":"Mathur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9379-4940","authenticated-orcid":false,"given":"Vibha","family":"Rani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,2]]},"reference":[{"key":"4473_CR1","volume-title":"IDF diabetes atlas","author":"International Diabetes Federation","year":"2019","unstructured":"International Diabetes Federation (2019) IDF diabetes atlas, 9th edn. Belgium, Brussels","edition":"9"},{"issue":"10","key":"4473_CR2","doi-asserted-by":"publisher","first-page":"490","DOI":"10.4239\/wjd.v10.i10.490","volume":"10","author":"L Athithan","year":"2019","unstructured":"Athithan L, Gulsin GS, McCann GP et al (2019) Diabetic cardiomyopathy: Pathophysiology, theories and evidence to date. World J Diabetes 10(10):490\u2013510","journal-title":"World J Diabetes"},{"key":"4473_CR3","doi-asserted-by":"publisher","first-page":"i3477","DOI":"10.1136\/bmj.i3477","volume":"354","author":"J Hippisley-Cox","year":"2016","unstructured":"Hippisley-Cox J, Coupland C (2016) Diabetes treatments and risk of heart failure, cardiovascular disease, and all cause mortality: cohort study in primary care. BMJ 354:i3477","journal-title":"BMJ"},{"issue":"8","key":"4473_CR4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.amjcard.2003.11.003","volume":"93","author":"A Avogaro","year":"2004","unstructured":"Avogaro A, de Kreutzenberg SV, Negut C et al (2004) Diabetic cardiomyopathy: a metabolic perspective. Am J Cardiol 93(8):13\u201316","journal-title":"Am J Cardiol"},{"issue":"6","key":"4473_CR5","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/0002-9149(72)90595-4","volume":"30","author":"S Rubler","year":"1972","unstructured":"Rubler S, Dlugash J, Yuceoglu YZ et al (1972) New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol 30(6):595\u2013602","journal-title":"Am J Cardiol"},{"issue":"5","key":"4473_CR6","first-page":"411","volume":"55","author":"K Trachanas","year":"2014","unstructured":"Trachanas K, Sideris S, Aggeli C et al (2014) Diabetic cardiomyopathy: from pathophysiology to treatment. Hell J Cardiol 55(5):411\u2013421","journal-title":"Hell J Cardiol"},{"issue":"1","key":"4473_CR7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s11154-010-9131-7","volume":"11","author":"S Boudina","year":"2010","unstructured":"Boudina S, Abel ED (2010) Diabetic cardiomyopathy, causes and effects. Rev Endocr Metab Disord 11(1):31\u201339","journal-title":"Rev Endocr Metab Disord"},{"issue":"3","key":"4473_CR8","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1210\/jc.2013-3519","volume":"99","author":"AS Shah","year":"2014","unstructured":"Shah AS, Gao Z, Urbina EM et al (2014) Prediabetes: the effects on rterial thickness and stiffness in obese youth. J Clin Endocrinol Metab 99(3):1037","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"4473_CR9","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1159\/000354998","volume":"127","author":"L Tian","year":"2014","unstructured":"Tian L, Zhu J, Liu L et al (2014) Prediabetes and short-term outcomes in nondiabetic patients after acute ST-elevation myocardial infarction. Cardiology 127(1):55\u201361","journal-title":"Cardiology"},{"issue":"8","key":"4473_CR10","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.metabol.2013.02.011","volume":"62","author":"D Erdogan","year":"2013","unstructured":"Erdogan D, Yucel H, Uysal BA et al (2013) Effects of pre-diabetes and diabetes on left ventricular and coronary microvascular functions. Metabolism 62(8):1123\u20131130","journal-title":"Metabolism"},{"issue":"1\u20132","key":"4473_CR11","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s11010-019-03618-4","volume":"462","author":"S Saxena","year":"2019","unstructured":"Saxena S, Mathur P, Shukla V et al (2019) Differential expression of novel MicroRNAs from developing fetal heart of Gallus gallus domesticus implies a role in cardiac development. Mol Cell Biochem 462(1\u20132):157\u2013165","journal-title":"Mol Cell Biochem"},{"issue":"2","key":"4473_CR12","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.gene.2012.09.066","volume":"511","author":"L Guo","year":"2012","unstructured":"Guo L, Sun B, Wu Q et al (2012) miRNA\u2013miRNA interaction implicates for potential mutual regulatory pattern. Gene 511(2):187\u2013194","journal-title":"Gene"},{"issue":"2","key":"4473_CR13","doi-asserted-by":"publisher","first-page":"e1004744","DOI":"10.1371\/journal.pcbi.1004744","volume":"12","author":"SW Paugh","year":"2016","unstructured":"Paugh SW, Coss DR, Bao J et al (2016) MicroRNAs form triplexes with double stranded DNA at sequence-specific binding sites; a eukaryotic mechanism via which microRNAs could directly alter gene expression. PLoS Comput Biol 12(2):e1004744","journal-title":"PLoS Comput Biol"},{"issue":"12","key":"4473_CR14","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1007\/s13205-018-1520-8","volume":"8","author":"S Saxena","year":"2018","unstructured":"Saxena S, Gupta A, Shukla V et al (2018) Functional annotation of differentially expressed fetal cardiac microRNA targets: implication for microRNA-based cardiovascular therapeutics. 3 Biotech 8(12):494","journal-title":"3 Biotech"},{"issue":"3","key":"4473_CR15","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.bbrc.2008.09.025","volume":"376","author":"XY Yu","year":"2008","unstructured":"Yu XY, Song YH, Geng YJ et al (2008) Glucose induces apoptosis of cardiomyocytes via microRNA-1 and IGF-1. Biochem Biophys Res Commun 376(3):548\u2013552","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"4473_CR16","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1038\/mt.2014.25","volume":"22","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Huang XR, Wei LH et al (2014) miR-29b as a therapeutic agent for angiotensin II-induced cardiac fibrosis by targeting TGF-\u03b2\/Smad3 signaling. Mol Ther 22(5):974\u2013985","journal-title":"Mol Ther"},{"issue":"6","key":"4473_CR17","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1007\/s11596-013-1207-7","volume":"33","author":"F Zhao","year":"2013","unstructured":"Zhao F, Li BO, Wei YZ et al (2013) MicroRNA-34a regulates high glucose-induced apoptosis in H9c2 cardiomyocytes. J Huazhong Univ Sci Technol\u2014Med Sci 33(6):834\u2013839","journal-title":"J Huazhong Univ Sci Technol\u2014Med Sci"},{"issue":"1","key":"4473_CR18","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00592-010-0226-0","volume":"48","author":"L Kong","year":"2011","unstructured":"Kong L, Zhu J, Han W et al (2011) Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study. Acta Diabetol 48(1):61\u201369","journal-title":"Acta Diabetol"},{"issue":"6","key":"4473_CR19","first-page":"5589","volume":"14","author":"Y Shen","year":"2017","unstructured":"Shen Y, Xu H, Pan X et al (2017) miR-34a and miR-125b are upregulated in peripheral blood mononuclear cells from patients with type 2 diabetes mellitus. Exp Ther Med 14(6):5589\u20135596","journal-title":"Exp Ther Med"},{"issue":"6","key":"4473_CR20","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1093\/eurheartj\/ehv599","volume":"37","author":"S Costantino","year":"2016","unstructured":"Costantino S, Paneni F, L\u00fcscher TF et al (2016) MicroRNA profiling unveils hyperglycaemic memory in the diabetic heart. Eur Heart J 37(6):572\u2013576","journal-title":"Eur Heart J"},{"key":"4473_CR21","doi-asserted-by":"publisher","DOI":"10.2174\/1566523221666210311111619","author":"P Mathur","year":"2021","unstructured":"Mathur P, Rani V (2021) MicroRNAs: a critical regulator and a promising therapeutic and diagnostic molecule for diabetic cardiomyopathy. Curr Gene Ther. https:\/\/doi.org\/10.2174\/1566523221666210311111619","journal-title":"Curr Gene Ther"},{"issue":"3","key":"4473_CR22","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1007\/s12012-013-9207-1","volume":"13","author":"N Atale","year":"2013","unstructured":"Atale N, Chakraborty M, Mohanty S et al (2013) Cardioprotective role of Syzygium cumini against glucose-induced oxidative stress in H9C2 cardiac myocytes. Cardiovasc Toxicol 13(3):278\u2013289","journal-title":"Cardiovasc Toxicol"},{"issue":"11","key":"4473_CR23","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1093\/cvr\/cvaa195","volume":"116","author":"C B\u00e4r","year":"2020","unstructured":"B\u00e4r C, Chatterjee S, Falc\u00e3o Pires I et al (2020) Non-coding RNAs: update on mechanisms and therapeutic targets from the ESC working groups of myocardial function and cellular biology of the heart. Cardiovasc Res 116(11):1805\u20131819","journal-title":"Cardiovasc Res"},{"issue":"12","key":"4473_CR24","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.3390\/cells8121533","volume":"8","author":"S Vasu","year":"2019","unstructured":"Vasu S, Kumano K, Darden CM et al (2019) MicroRNA signatures as future biomarkers for diagnosis of diabetes states. Cells 8(12):1533","journal-title":"Cells"},{"issue":"27","key":"4473_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yclnex.2019.07.001","volume":"1","author":"FH Yerlikaya","year":"2019","unstructured":"Yerlikaya FH, \u00d6z M (2019) Aberrant expression of miRNA profiles in high-fat and high-sucrose fed rats. Clin Nutr Exp 1(27):1\u20138","journal-title":"Clin Nutr Exp"},{"issue":"2","key":"4473_CR26","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s11626-010-9368-1","volume":"47","author":"SJ Watkins","year":"2011","unstructured":"Watkins SJ, Borthwick GM, Arthur HM (2011) The H9C2 cell line and primary neonatal cardiomyocyte cells show similar hypertrophic responses in vitro. In Vitro Cell Dev Biol-Anim 47(2):125\u2013131","journal-title":"In Vitro Cell Dev Biol-Anim"},{"issue":"Supplement 1","key":"4473_CR27","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.2337\/dc14-S081","volume":"37","author":"American Diabetes Association","year":"2014","unstructured":"American Diabetes Association (2014) Diagnosis and classification of diabetes mellitus. Diabetes Care 37(Supplement 1):S81-90","journal-title":"Diabetes Care"},{"issue":"6","key":"4473_CR28","doi-asserted-by":"publisher","first-page":"E1119","DOI":"10.1152\/ajpendo.00029.2008","volume":"294","author":"B Feng","year":"2008","unstructured":"Feng B, Chen S, Chiu J et al (2008) Regulation of cardiomyocyte hypertrophy in diabetes at the transcriptional level. Am J Physiol-Endocrinol Metab 294(6):E1119\u2013E1126","journal-title":"Am J Physiol-Endocrinol Metab"},{"issue":"3","key":"4473_CR29","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1159\/000481758","volume":"43","author":"F Yang","year":"2017","unstructured":"Yang F, Zhang L, Gao Z et al (2017) Exogenous H2S protects against diabetic cardiomyopathy by activating autophagy via the AMPK\/mTOR pathway. Cell Physiol Biochem 43(3):1168\u20131187","journal-title":"Cell Physiol Biochem"},{"issue":"1","key":"4473_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-13875-2","volume":"7","author":"CU Copier","year":"2017","unstructured":"Copier CU, Le\u00f3n L, Fern\u00e1ndez M et al (2017) Circulating miR-19b and miR-181b are potential biomarkers for diabetic cardiomyopathy. Sci Rep 7(1):1\u20131","journal-title":"Sci Rep"},{"issue":"1","key":"4473_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep37354","volume":"6","author":"D de Gonzalo-Calvo","year":"2016","unstructured":"de Gonzalo-Calvo D, Kenneweg F, Bang C et al (2016) Circulating long-non coding RNAs as biomarkers of left ventricular diastolic function and remodelling in patients with well-controlled type 2 diabetes. Sci Rep 6(1):1\u20132","journal-title":"Sci Rep"},{"issue":"1","key":"4473_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-015-0672-0","volume":"13","author":"L Fang","year":"2015","unstructured":"Fang L, Ellims AH, Moore XL et al (2015) Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy. J Transl Med 13(1):1\u20132","journal-title":"J Transl Med"},{"issue":"1","key":"4473_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms2090","volume":"3","author":"A Ucar","year":"2012","unstructured":"Ucar A, Gupta SK, Fiedler J et al (2012) The miRNA-212\/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy. Nat Commun 3(1):1\u20131","journal-title":"Nat Commun"},{"issue":"256","key":"4473_CR34","doi-asserted-by":"publisher","first-page":"117980","DOI":"10.1016\/j.lfs.2020.117980","volume":"1","author":"D Xu","year":"2020","unstructured":"Xu D, Zhang X, Chen X et al (2020) Inhibition of miR-223 attenuates the NLRP3 inflammasome activation, fibrosis, and apoptosis in diabetic cardiomyopathy. Life Sci 1(256):117980","journal-title":"Life Sci"},{"key":"4473_CR35","doi-asserted-by":"publisher","DOI":"10.2337\/db20-23-LB","author":"J Zhou","year":"2020","unstructured":"Zhou J, Zhu Y, Fan J (2020) 23-LB: overexpression of microRNA-16 derepresses the mitochondrial function to exacerbate cardiomyopathy in streptozotocin-induced diabetic mice. Diabetes. https:\/\/doi.org\/10.2337\/db20-23-LB","journal-title":"Diabetes"},{"issue":"1","key":"4473_CR36","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s12013-013-9679-4","volume":"68","author":"V Chavali","year":"2014","unstructured":"Chavali V, Tyagi SC, Mishra PK (2014) Differential expression of dicer, miRNAs, and inflammatory markers in diabetic Ins2+\/\u2212 Akita hearts. Cell Biochem Biophys 68(1):25\u201335","journal-title":"Cell Biochem Biophys"},{"issue":"4","key":"4473_CR37","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.bbrc.2016.02.065","volume":"471","author":"P Jeyabal","year":"2016","unstructured":"Jeyabal P, Thandavarayan RA, Joladarashi D et al (2016) MicroRNA-9 inhibits hyperglycemia-induced pyroptosis in human ventricular cardiomyocytes by targeting ELAVL1. Biochem Biophys Res Commun 471(4):423\u2013429","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"4473_CR38","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1002\/jcp.29119","volume":"235","author":"Z Wang","year":"2020","unstructured":"Wang Z, Wang Z, Gao L et al (2020) miR-222 inhibits cardiac fibrosis in diabetic mice heart via regulating Wnt\/\u03b2-catenin-mediated endothelium to mesenchymal transition. J Cell Physiol 235(3):2149\u20132160","journal-title":"J Cell Physiol"},{"issue":"1","key":"4473_CR39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-016-0001-8","volume":"6","author":"SS Babu","year":"2016","unstructured":"Babu SS, Thandavarayan RA, Joladarashi D et al (2016) MicroRNA-126 overexpression rescues diabetes-induced impairment in efferocytosis of apoptotic cardiomyocytes. Sci Rep 6(1):1\u20132","journal-title":"Sci Rep"},{"issue":"35","key":"4473_CR40","doi-asserted-by":"publisher","first-page":"13027","DOI":"10.1073\/pnas.0805038105","volume":"105","author":"E Van Rooij","year":"2008","unstructured":"Van Rooij E, Sutherland LB, Thatcher JE et al (2008) Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci 105(35):13027\u201313032","journal-title":"Proc Natl Acad Sci"},{"issue":"18_Supplement_1","key":"4473_CR41","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/S0735-1097(21)02009-X","volume":"77","author":"J Diao","year":"2021","unstructured":"Diao J, Cheng G, Zhao H et al (2021) Mir-148a attenuated oxidative stress in diabetic cardiomyopathy by negatively regulating crlreticulin. J Am Coll Cardiol 77(18_Supplement_1):650\u2013650","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"4473_CR42","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1042\/CS20160916","volume":"131","author":"S Rawal","year":"2017","unstructured":"Rawal S, Munasinghe PE, Nagesh PT et al (2017) Down-regulation of miR-15a\/b accelerates fibrotic remodelling in the type 2 diabetic human and mouse heart. Clin Sci 131(9):847\u2013863","journal-title":"Clin Sci"},{"issue":"8","key":"4473_CR43","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1002\/jcp.25280","volume":"231","author":"EC Guedes","year":"2016","unstructured":"Guedes EC, Franca GS, Lino CA et al (2016) MicroRNA expression signature is altered in the cardiac remodeling induced by high fat diets. J Cell Physiol 231(8):1771\u20131783","journal-title":"J Cell Physiol"},{"issue":"10","key":"4473_CR44","doi-asserted-by":"publisher","first-page":"e1479","DOI":"10.1038\/cddis.2014.430","volume":"5","author":"X Li","year":"2014","unstructured":"Li X, Du N, Zhang Q et al (2014) MicroRNA-30d regulates cardiomyocyte pyroptosis by directly targeting foxo3a in diabetic cardiomyopathy. Cell Death Dis 5(10):e1479\u2013e1479","journal-title":"Cell Death Dis"},{"issue":"1","key":"4473_CR45","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"DW Huang","year":"2009","unstructured":"Huang DW, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4(1):44\u201357","journal-title":"Nat Protoc"},{"issue":"12","key":"4473_CR46","doi-asserted-by":"publisher","first-page":"3082","DOI":"10.2337\/diabetes.53.12.3082","volume":"53","author":"IS Harris","year":"2004","unstructured":"Harris IS, Treskov I, Rowley MW et al (2004) G-protein signaling participates in the development of diabetic cardiomyopathy. Diabetes 53(12):3082\u20133090","journal-title":"Diabetes"},{"issue":"1","key":"4473_CR47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-016-0001-8","volume":"6","author":"HE Wu","year":"2016","unstructured":"Wu HE, Baumgardt SL, Fang J et al (2016) Cardiomyocyte GTP cyclohydrolase 1 protects the heart against diabetic cardiomyopathy. Sci Rep 6(1):1\u20134","journal-title":"Sci Rep"},{"issue":"4","key":"4473_CR48","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.cmet.2005.09.005","volume":"2","author":"L Eguez","year":"2005","unstructured":"Eguez L, Lee A, Chavez JA et al (2005) Full intracellular retention of GLUT4 requires AS160 Rab GTPase activating protein. Cell Metab 2(4):263\u2013272","journal-title":"Cell Metab"},{"issue":"45","key":"4473_CR49","doi-asserted-by":"publisher","first-page":"37803","DOI":"10.1074\/jbc.M503897200","volume":"280","author":"M Larance","year":"2005","unstructured":"Larance M, Ramm G, St\u00f6ckli J et al (2005) Characterization of the role of the Rab GTPase-activating protein AS160 in insulin-regulated GLUT4 trafficking. J Biol Chem 280(45):37803\u201337813","journal-title":"J Biol Chem"},{"issue":"9","key":"4473_CR50","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s11427-012-4369-9","volume":"55","author":"X Jiang","year":"2012","unstructured":"Jiang X, Zhang JT, Chan HC (2012) Ion channels\/transporters as epigenetic regulators?\u2014a microRNA perspective. Sci China Life Sci 55(9):753\u2013760","journal-title":"Sci China Life Sci"},{"issue":"3","key":"4473_CR51","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/j.1527-5299.2002.00716.x","volume":"8","author":"G Choudhary","year":"2002","unstructured":"Choudhary G, Dudley SC Jr (2002) Heart failure, oxidative stress, and ion channel modulation. Congest Heart Fail 8(3):148\u2013155","journal-title":"Congest Heart Fail"},{"issue":"3","key":"4473_CR52","doi-asserted-by":"publisher","first-page":"214","DOI":"10.2174\/1566523217666170707100026","volume":"17","author":"S Saxena","year":"2017","unstructured":"Saxena S, Jain A, Rani V (2017) MicroRNA-mediated MMP regulation: current diagnostic and therapeutic strategies for metabolic syndrome. Curr Gene Ther 17(3):214\u2013227","journal-title":"Curr Gene Ther"},{"issue":"1","key":"4473_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s10020-020-00200-3","volume":"26","author":"C Wang","year":"2020","unstructured":"Wang C, Zhao J, Nan X et al (2020) Long noncoding RNA CASC2 inhibits ox-LDL-mediated vascular smooth muscle cells proliferation and migration via the regulation of miR-532-3p\/PAPD5. Mol Med 26(1):1\u20139","journal-title":"Mol Med"},{"key":"4473_CR54","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1007\/s10495-020-01609-1","volume":"25","author":"DN Chandrasekera","year":"2020","unstructured":"Chandrasekera DN, Neale JP, van Hout I et al (2020) Upregulation of microRNA-532 enhances cardiomyocyte apoptosis in the diabetic heart. Apoptosis 25:388\u2013399","journal-title":"Apoptosis"},{"issue":"3","key":"4473_CR55","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1097\/SLA.0b013e3182a15bcc","volume":"258","author":"Z Kanaan","year":"2013","unstructured":"Kanaan Z, Roberts H, Eichenberger MR et al (2013) A plasma microRNA panel for detection of colorectal adenomas: a step toward more precise screening for colorectal cancer. Ann Surg 258(3):400\u2013408","journal-title":"Ann Surg"},{"issue":"648","key":"4473_CR56","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.gene.2018.01.047","volume":"30","author":"Y Lu","year":"2018","unstructured":"Lu Y, Wu F (2018) A new miRNA regulator, miR-672, reduces cardiac hypertrophy by inhibiting JUN expression. Gene 30(648):21\u201330","journal-title":"Gene"},{"issue":"9","key":"4473_CR57","doi-asserted-by":"publisher","first-page":"904","DOI":"10.3389\/fphar.2018.00904","volume":"10","author":"CD Lucia","year":"2018","unstructured":"Lucia CD, Eguchi A, Koch WJ (2018) New insights in cardiac \u03b2-adrenergic signaling during heart failure and aging. Front Pharmacol 10(9):904","journal-title":"Front Pharmacol"},{"issue":"3","key":"4473_CR58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/ijmm.2021.4858","volume":"47","author":"P Zhao","year":"2021","unstructured":"Zhao P, Wang Y, Zhang L, Zhang J, Liu N, Wang H (2021) Mechanism of long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 in lipid metabolism and inflammation in heart failure. Int J Mol Med 47(3):1","journal-title":"Int J Mol Med"},{"key":"4473_CR59","doi-asserted-by":"publisher","DOI":"10.1089\/neu.2021.0464","author":"Z Zhou","year":"2022","unstructured":"Zhou Z, Li C, Bao T, Zhao X, Xiong W, Luo C, Yin G, Fan J (2022) Exosome-shuttled miR-672\u20135p from anti-inflammatory microglia repair traumatic spinal cord injury by inhibiting AIM2\/ASC\/Caspase-1 signaling pathway mediated neuronal pyroptosis. J Neurotrauma. https:\/\/doi.org\/10.1089\/neu.2021.0464","journal-title":"J Neurotrauma"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-022-04473-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-022-04473-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-022-04473-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T12:48:57Z","timestamp":1744202937000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-022-04473-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,2]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["4473"],"URL":"https:\/\/doi.org\/10.1007\/s11010-022-04473-6","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,2]]},"assertion":[{"value":"19 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There is no conflict of interest between the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study did not require any ethical approval.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}